(NasdaqGM:SKYE), LOS ANGELES, Jan. 06, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Skye Bioscience, Inc., (“Skye” or the “Company”) (NASDAQ: SKYE) investors of a class action on behalf of investors that bought securities between November 4, 2024 and October 3, 2025, inclusive (the “Class Period”). Skye investors have until January 16, 2026 to […]
Photonic Raises $180M CAD ($130M USD) to Accelerate Quantum Computing and Networking Planet First Partners leads round, reinforcing commitment to climate-focused technology GlobeNewswire January 06, 2026 VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) — Photonic Inc., a global leader in distributed quantum computing, announced today that it has raised $180M CAD ($130M USD) in
Portnoy Law Firm Announces Class Action on Behalf of Perrigo Company plc Investors GlobeNewswire January 06, 2026 LOS ANGELES, Jan. 06, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Perrigo Company plc, (“Perrigo” or the “Company”) (NYSE: PRGO) investors of a class action on behalf of investors that bought securities between February 27, 2023
Portnoy Law Firm Announces Class Action on Behalf of Skye Bioscience, Inc. Investors GlobeNewswire January 06, 2026 LOS ANGELES, Jan. 06, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Skye Bioscience, Inc., (“Skye” or the “Company”) (NASDAQ: SKYE) investors of a class action on behalf of investors that bought securities between November 4, 2024
NEW YORK, NY / ACCESS Newswire / January 6, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (NYSE:LRN) securities. If you suffered a loss on your Stride investment and would like to explore a potential recovery
LOS ANGELES, Jan. 06, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises NowRX, Inc., (“NowRX” or the “Company”) investors of a class action on behalf of investors that bought securities between February 1, 2022 and November 5, 2022, inclusive (the “Class Period”). NowRX investors have until January 23, 2026 to file a lead plaintiff
(NasdaqGM:FLY), LOS ANGELES, Jan. 06, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Firefly Aerospace, Inc. (“Firefly” or the “Company”) (NASDAQ: FLY) investors of a class action on behalf of investors that bought securities between August 7, 2025 and September 29, 2025, inclusive (the “Class Period”). Firefly investors have until January 12, 2026 to
TUSCALOOSA, Ala., Jan. 06, 2026 (GLOBE NEWSWIRE) — PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated chronic illnesses including Long COVID, today announced two major milestones supporting the advancement of its planned SHIELD Study, a randomized, double-blind, placebo-controlled Phase 2 Long COVID clinical study. This study will be conducted in collaboration with
Portnoy Law Firm Announces Class Action on Behalf of NowRX, Inc. Investors GlobeNewswire January 06, 2026 LOS ANGELES, Jan. 06, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises NowRX, Inc., (“NowRX” or the “Company”) investors of a class action on behalf of investors that bought securities between February 1, 2022 and November 5, 2022,
PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVID Program GlobeNewswire January 06, 2026 TUSCALOOSA, Ala., Jan. 06, 2026 (GLOBE NEWSWIRE) — PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated chronic illnesses including Long COVID, today announced two major milestones